Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

A 70104

Known as: A-70104 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2004
Highly Cited
2004
CCK type 1 (CCK1) receptor antagonists differing in blood-brain barrier permeability were used to test the hypothesis that… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2003
2003
Type A cholecystokinin receptor (CCKAR) antagonists differing in blood-brain barrier permeability were used to test the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2003
2003
Type A cholecystokinin receptor (CCKAR) antagonists differing in blood-brain barrier permeability were used to test the… Expand
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2003
2003
Type A CCK receptor (CCKAR) antagonists differing in blood-brain barrier permeability [devazepide penetrates; the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1992
1992
The anorectic actions of cholecystokinin (CCK)-8 and of a selective CCK-A agonist, A-71623, were examined in CD1 mice, beagle… Expand
Is this relevant?
1992
1992
Boc-Tyr(SO3)-Nle-Gly-Trp-Nle-Asp-2-phenylether ester (CCK-JMV-180) has been reported to be a CCK-based heptipeptide with novel in… Expand
Is this relevant?